Palvella Therapeutics, Inc.

Q3 2026 13F Holders

Symbol
PVLA
CUSIP
697947109
Type
Equity
Class
COM
Num filers
202
Total reported value, excl. options
$2.01B
Manager Report Date Value ($000) Shares